All In MedTech

Device Trial Radar · NCT02518100

Vital Signs Patch: Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting

Vital Signs Patch: Early Feasibility and Usability Study - Feasibility Study for Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting

Last checked: Nov 20, 2026Latest source record: Apr 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Sep 22, 2015

Primary completion

Aug 16, 2016

Study completion Apr 10, 2017

Sponsor

Lead sponsor
LifeWatch Services, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 7, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This feasibility study evaluates the use of the Vital Signs Patch (VSP) System to take and monitor specified vital signs. It will be used in parallel with the normal equipment the study site uses to take and monitor vital signs.

Conditions

  • Automated Measurement of Vital Signs

Interventions

  • Vital Signs Patch (VSP) System 3-Lead (NEHB) ConfigurationDevice

    Vital signs will be taken using the Vital Signs Patch (VSP) System 3-Lead (NEHB) Configuration on each study participant in each Arm of this study for comparison against the same vital signs taken with traditional methods used by the facility.

  • Vital Signs Patch (VSP) System 1-Lead (PAL) ConfigurationDevice

    Vital signs will be taken using the Vital Signs Patch (VSP) System 1-Lead (PAL) Configuration on each study participant in each Arm of this study for comparison against the same vital signs taken with traditional methods used by the facility.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite Outcome Measure - Successful Vital Signs AcquisitionTime frame: Up to Four Days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Cleveland Clinic

    Cleveland, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.